Drug Policy Modelling Program, Social Policy Research Centre, UNSW Sydney, Sydney, Australia.
Centre for Rural Criminology, School of Humanities, Arts and Social Sciences, University of New England, Armidale, Australia.
Drug Alcohol Rev. 2020 Feb;39(2):189-197. doi: 10.1111/dar.13027.
Governments across the globe invest considerable amounts in funding alcohol and other drug (AOD) treatment. Little attention however has been paid to the ways AOD service providers are chosen and how they are paid. This study sought to examine the perceptions of Australian AOD treatment purchasers and providers regarding different purchasing and payment mechanisms.
Qualitative interviews with AOD treatment providers and purchasers (N = 197) were undertaken across the eight Australian states/territories and the Commonwealth. Data were collated against six main AOD treatment purchasing and payment mechanisms (as identified in the literature), then an inductive, comparative analysis to assign codes was conducted, followed by interpretive analysis to explore emergent themes.
Five main themes were identified in relation to AOD treatment payment and purchasing mechanisms: (i) applying private sector principles to purchasing; (ii) innovation, sector stability and addressing client needs; (iii) performance monitoring and measuring outcomes; (iv) the threat to designated funding for AOD treatment; and (v) the costs and benefits of having multiple funding sources.
In many countries reforms are taking place in the health sector consistent with New Public Management principles. These principles, when applied to AOD treatment, have included introducing competition, output and outcomes-based funding models, standards and accountability. Purchaser and providers identified both strengths and weaknesses and highlighted the overarching concern that implementation of any (mix) of these mechanisms should always be underpinned by a client-centred and not a finance-centred approach.
全球各国政府在为酒精和其他药物(AOD)治疗提供资金方面投入了大量资金。然而,人们很少关注 AOD 服务提供商的选择方式以及他们的薪酬方式。本研究旨在探讨澳大利亚 AOD 治疗购买者和提供者对不同购买和支付机制的看法。
在澳大利亚八个州/地区和英联邦进行了与 AOD 治疗提供者和购买者(N=197)的定性访谈。数据是根据文献中确定的六种主要 AOD 治疗购买和支付机制(即)收集的,然后进行归纳性、比较性分析以分配代码,然后进行解释性分析以探索出现的主题。
与 AOD 治疗支付和购买机制相关,确定了五个主要主题:(i)将私营部门原则应用于采购;(ii)创新、部门稳定性和满足客户需求;(iii)绩效监测和衡量结果;(iv)AOD 治疗指定资金的威胁;(v)拥有多个资金来源的成本和收益。
在许多国家,卫生部门正在按照新公共管理原则进行改革。当这些原则应用于 AOD 治疗时,包括引入竞争、基于产出和结果的资金模式、标准和问责制。购买者和提供者都确定了这些机制的优缺点,并强调了一个首要关注的问题,即任何(混合)机制的实施都应始终以以客户为中心而不是以财务为中心的方法为基础。